Filing Details
- Accession Number:
- 0001567619-20-013331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-16 11:31:08
- Reporting Period:
- 2020-07-15
- Accepted Time:
- 2020-07-16 11:31:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1509261 | Rezolute Inc. | RZLT | Pharmaceutical Preparations (2834) | 273440894 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1798101 | Handok, Inc. | 132, Teheran-Ro Gangman Gu Seoul M4 06235 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-07-15 | 250,000 | $0.16 | 92,277,587 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2020.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.157 to $0.167, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2).
Billionaire Hedge Funds
